Neuspera Medical Inc. | LinkedIn (original) (raw)

Medical Device

San Jose, CA 8,697 followers

empowering patients to reclaim their lives

View all 45 employees

About us

Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. With the first intended indication for use as Urinary Urgency Incontinence (UUI), the platform technology is ultimately designed to deliver targeted bioelectronic medicine for a variety of conditions. Neuspera’s minimally-invasive implants with external wearable transmitters offer the possibility for therapies to reach deeper, harder to access anatomical locations in the body.

Industry

Medical Device

Company size

11-50 employees

Headquarters

San Jose, CA

Type

Privately Held

Specialties

Neuromodulation and Neurostimulation

Locations

Employees at Neuspera Medical Inc.

Updates

We are happy to be part of the amazing AdvaMed community and participate at The Medtech Conference in Toronto October 15-17.#MedTechCon #OAB #Neuromodulation #urology #innovation
I’m excited to be speaking at The MedTech Conference, October 15-17 in Toronto on MedTech Innovator Showcase: Urology Tech - Urine Luck. I’m looking forward to engaging with my global medtech community and discussing the latest industry trends and innovations. The cross-cutting #MTC24 agenda will educate and provide solutions for the critical issues that will impact the entire health care industry. I hope to see you in Toronto #MedTechCon
We are thrilled to welcome Bunty Banerjee as our first-ever chief operating officer! Bunty comes to us with deep medical device leadership experience and will lead activities in both research and development, as well as operations, while working closely with all other functions as we complete the FDA submission for regulatory approval of the Neuspera System to treat OAB symptoms and prepare for commercialization. Read more about this exciting news over at the Neuspera website: https://lnkd.in/gnf3kwpC.#NeusperaSystem #OAB #urology #incontinence #neuromodulation #newemployee
We’re pleased to share that we’ve achieved a significant milestone: The last patient in the SANS-UUI pivotal clinical trial has completed their primary endpoint visit! The SANS-UUI multi-center clinical study was designed to demonstrate the safety and efficacy of the Neuspera System and gain FDA approval in the U.S. “We’re grateful to every physician and patient who participated in the clinical trial, and we’re excited that our uniquely differentiated technology will be available to millions of patients when it is FDA-approved for treatment of OAB symptoms,” said Steffen Hovard, CEO of Neuspera Medical. “The fact that the market is only 5% penetrated at this time is a clear indication that patients are looking for something different than what's available today. The Neuspera System delivers true innovation.” Check out the news here: https://lnkd.in/gygMz_AF. #OAB #urology #incontinence #neuromodulation
Neuspera Medical Inc. reposted this
Neuspera Medical Inc. (#LSIAlumni) closed a $23M Series D funding round led by Vertex Ventures HC and Treo Ventures. The round also had participation from Action Potential Venture Capital, Windham Venture Partners, Olympus Corporation Innovation Ventures, and another strategic investor. This round will fund the company through expected FDA premarket approval of the Neuspera System. The system is a discreet, minimally invasive, ultra-miniaturized implant designed to provide patients personal control and relief from urinary urge incontinence (UUI), a symptom of overactive bladder (OAB). It's the least invasive sacral neuromodulation device and includes an ultra-miniaturized pulse generator attached to an electrode array. The Neuspera System has FDA clearance for treating chronic pain of peripheral nerve origin and is currently an investigational device for treating UUI, a symptom associated with OAB. Congratulations to LSI Alumni, Steffen Hovard and the entire Neuspera Medical team on this major milestone! We look forward to following along your journey. Watch Steffen’s full LSI USA ‘24 presentation to learn more about Neuspera Medical - Available on our website and YouTube channel.
8,697 followers
2mo Edited
We’re pleased to announce the closing of our $23 million Series D funding round, led by Vertex Ventures HC and Treo Ventures with participation by Action Potential Venture Capital, Windham Capital Partners, Olympus Corporation Innovation Ventures and another strategic investor. We’re extremely grateful to this group of investors for their partnership and support which will provide funding through expected U.S. Food and Drug Association premarket approval of the Neuspera System, the discreet, minimally invasive, ultra-miniaturized implant designed to provide patients personal control and relief from urinary urge incontinence a symptom of overactive bladder. More details are available at in the press release, here: https://lnkd.in/de_f9u2F.#OAB #urology #neuromodulation #medtech

Join now to see what you are missing

Join now

Neuspera Medical Inc. | LinkedIn (original) (raw)

Medical Device

San Jose, CA 8,697 followers

empowering patients to reclaim their lives

About us

Locations

Employees at Neuspera Medical Inc.

Updates

Join now to see what you are missing

Similar pages

Browse jobs

Funding